Professor Adam E. Frampton

Professor Adam E. Frampton

Imperial College London

H-index: 42

Europe-United Kingdom

About Professor Adam E. Frampton

Professor Adam E. Frampton, With an exceptional h-index of 42 and a recent h-index of 33 (since 2020), a distinguished researcher at Imperial College London, specializes in the field of microRNAs, Immuno-Oncology, Pancreatic Cancer, Biomarkers, General/HPB Surgery.

His recent articles reflect a diverse array of research interests and contributions to the field:

Bile Microbiome Signatures as Biomarkers for Differentiating Pancreatic Ductal Adenocarcinoma from Benign Disease: Discovery of novel microbial signatures in a UK pilot study

The Roles and Interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in Oral and Gastrointestinal Carcinogenesis: A Narrative Review

Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells

Current Practice in the Treatment of Colorectal Liver Metastases by Irreversible Electroporation: A Focus-Group International Questionnaire Survey (LIVERMET-IRE-Q).

Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer

Profile the intratumoural bacterial profiles in PDAC short term and long-term survivors and their association with transcriptomic subtypes and disease outcomes

Investigation into the immune microenvironment and microbiome in healthy, non-diseased bladder

Blood-based differentiation of malignant and benign pancreatic lesions using analysis of fragmentation patterns in cell-free DNA

Professor Adam E. Frampton Information

University

Position

Hon. Clinical Lecturer Dept. of Surgery & Cancer ; Hunterian Professor

Citations(all)

5274

Citations(since 2020)

3052

Cited By

3314

hIndex(all)

42

hIndex(since 2020)

33

i10Index(all)

95

i10Index(since 2020)

70

Email

University Profile Page

Imperial College London

Google Scholar

View Google Scholar Profile

Professor Adam E. Frampton Skills & Research Interests

microRNAs

Immuno-Oncology

Pancreatic Cancer

Biomarkers

General/HPB Surgery

Top articles of Professor Adam E. Frampton

Title

Journal

Author(s)

Publication Date

Bile Microbiome Signatures as Biomarkers for Differentiating Pancreatic Ductal Adenocarcinoma from Benign Disease: Discovery of novel microbial signatures in a UK pilot study

European Journal of Surgical Oncology

Nabeel Merali

Julien Terroire

Maria Danae Jessel

Ayse Demirkan

Nicola Annells

...

2024/1/1

The Roles and Interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in Oral and Gastrointestinal Carcinogenesis: A Narrative Review

Bing Wang

Juan Deng

Valentina Donati

Nabeel Merali

Adam E Frampton

...

2024/1/20

Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells

International Journal of Radiation Oncology* Biology* Physics

Pei Pei Che

Alessandro Gregori

Cecilia Bergonzini

Mahsoem Ali

Giulia Mantini

...

2024/4/1

Current Practice in the Treatment of Colorectal Liver Metastases by Irreversible Electroporation: A Focus-Group International Questionnaire Survey (LIVERMET-IRE-Q).

Harry VM Spiers

Saurabh Jamdar

Santhalingam Jegatheeswaran

Nicola De Liguori Carino

Panagiotis Stathakis

...

2024/4/3

Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer

The Journal of Liquid Biopsy

Lenka NC Boyd

Mahsoem Ali

Jisce R Puik

Annalisa Comandatore

Laura Ginocchi

...

2024/9/1

Profile the intratumoural bacterial profiles in PDAC short term and long-term survivors and their association with transcriptomic subtypes and disease outcomes

European Journal of Surgical Oncology

Nabeel Merali

Satoshi Suyama

Maria Danae Jessel

Virginia Pedicord

Nicola Annels

...

2024/1/1

Investigation into the immune microenvironment and microbiome in healthy, non-diseased bladder

European Journal of Surgical Oncology

Madhavi Natarajan

Tyler Wooldridge

Izhar Bagwan

Ben Haagsma

Nicola Annels

...

2024/1/1

Blood-based differentiation of malignant and benign pancreatic lesions using analysis of fragmentation patterns in cell-free DNA

Cancer Research

Clayton T Marcinak

Michelle D Stephens

Bradon R McDonald

Nabeel Merali

Stephanie M McGregor

...

2024/3/22

Impact of tertiary lymphoid structures on prognosis and therapeutic response in Pancreatic Ductal Adenocarcinoma

Nabeel Merali

Maria-Danae Jessel

Edward H Arbe-Barnes

Wing Yu Ruby Lee

Martha Gismondi

...

2024/4/26

Gene of the month: cancer testis antigen gene 1b (NY-ESO-1)

Journal of Clinical Pathology

Max Julve

Oliver Kennedy

Adam Enver Frampton

Izhar Bagwan

Mark P Lythgoe

2023/10/19

MicroRNAs derived from pre-operative bile shows differential expression in pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA)

European Journal of Surgical Oncology

Daniel Liu

Long Jiao

Jonathan Krell

Adam Frampton

2024/1/1

Metaverse and Telementoring: From Surgery to Workshop

Surgical Innovation

Michele Ammendola

Francesca Vescio

Mohanad Al Ansari

Jozel Hila

Laura Rizzo

...

2024/2/20

Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study

HPB

Ashray Rajagopalan

Somaiah Aroori

Thomas B Russell

Peter L Labib

Fabio Ausania

...

2024/4/26

Increasing tumour infiltrating lymphocytes through exercise alone in oesophageal adenocarcinoma

European Journal of Surgical Oncology

Charles Rayner

Sophie Allen Allen

Tadd Seymour Seymour

Shaun Preston Preston

Adam E Frampton

...

2024/1/1

Simultaneous resections for colorectal cancer with synchronous liver metastases: Current state-of-the-art

Nikolaos Machairas

Marcello Di Martino

Florian Primavesi

Patrick Underwood

Martin de Santibanes

...

2024/2/9

Standard Nutritional Assessment Tools Are Unable to Predict Loss of Muscle Mass in Patients Due to Undergo Pancreatico-Duodenectomy: Highlighting the Need for Detailed …

Nutrients

Mary E Phillips

M Denise Robertson

Kate Bennett-Eastley

Lily Rowe

Adam E Frampton

...

2024/4/25

Inhibition of peroxisome metabolism as a novel approach to selectively kill hypoxic triple negative breast cancer cells

European Journal of Surgical Oncology

Einthavy Arunachalam

Adam Frampton

Hannah Bolland

2024/1/1

Do some patients receive unnecessary parenteral nutrition after pancreatoduodenectomy? Results from an international multicentre study

Annals of Hepato-biliary-pancreatic Surgery

Thomas B Russell

Peter L Labib

Paula Murphy

Fabio Ausania

Elizabeth Pando

...

2024/2/2

Current postoperative nutritional practice after pancreatoduodenectomy in the UK: national survey and snapshot audit

BJS open

James M Halle-Smith

Samir Pathak

Adam Frampton

Sanjay Pandanaboyana

Robert P Sutcliffe

...

2024/4

Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for distal cholangiocarcinoma: An international multicentre retrospective cohort study

European Journal of Surgical Oncology

Peter LZ Labib

Thomas B Russell

Jemimah L Denson

Mark A Puckett

Fabio Ausania

...

2024/4/22

See List of Professors in Professor Adam E. Frampton University(Imperial College London)

Co-Authors

H-index: 88
Justin Stebbing

Justin Stebbing

Imperial College London

H-index: 80
Christopher Heeschen

Christopher Heeschen

Shanghai Jiao Tong University

H-index: 80
George B Hanna

George B Hanna

Imperial College London

H-index: 68
Nigel B Jamieson

Nigel B Jamieson

University of Glasgow

H-index: 66
Elisa Giovannetti

Elisa Giovannetti

Vrije Universiteit Amsterdam

H-index: 48
Thomas Knösel

Thomas Knösel

Ludwig-Maximilians-Universität München

academic-engine